GlassScriptPhysician profile
Helen Stosel
NPI 1952337362
$2,185.20
in general payments reported to CMS, 2019-2025
25 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $117 · 2021: $199 · 2022: $143 · 2023: $307 · 2024: $649 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,307.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $644.62 | 2019-2025 | Ubrelvy, Synthroid |
| Novo Nordisk INC | $391.71 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $348.00 | 2019-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $110.38 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Insulet Corporation | $102.04 | 2019-2024 | Omnipod |
| Amgen INC. | $62.21 | 2019-2025 | Tepezza |
| Dexcom, INC. | $54.54 | 2021-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.35 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $46.48 | 2023-2024 | |
| Medtronic, INC. | $39.51 | 2021-2024 | Minimed 780g |
| Beta Bionics, INC. | $33.75 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $31.17 | 2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $29.50 | 2025 | Yorvipath |
| Recordati_rare_diseases_inc. | $27.76 | 2025 | Isturisa |
| Ibsa Pharma INC. | $25.30 | 2020-2023 | Tirosint, Licart |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $23.59 | 2020 | |
| Mannkind Corporation | $22.87 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.70 | 2019 | |
| Harmony Biosciences LLC | $20.98 | 2023 | Wakix |
| Xeris Pharmaceuticals, INC. | $20.81 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $17.77 | 2024 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $17.17 | 2019 | |
| Cequr Corporation | $14.15 | 2024 | Cequr Simplicity |
| Merck Sharp & Dohme LLC | $13.41 | 2019 | |
| Endo Pharmaceuticals INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Stosel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.